Degmacyte
A degmacyte, commonly referred to as a bite cell, is a type of red blood cell that has a distinctive appearance due to the removal of a portion of the cell membrane. This removal is typically caused by the action of the spleen as it filters out damaged or abnormal cells from the bloodstream.
Formation[edit]
Degmacytes are primarily formed as a result of oxidative stress on red blood cells. This stress can lead to the formation of Heinz bodies, which are aggregates of denatured hemoglobin. The spleen recognizes these Heinz bodies as abnormal and removes them, resulting in the "bite" appearance of the cell.
Clinical Significance[edit]
The presence of degmacytes in a blood smear is often associated with certain hemolytic anemias, particularly those involving oxidative damage to red blood cells. Conditions such as glucose-6-phosphate dehydrogenase deficiency (G6PD deficiency) can lead to the formation of degmacytes. In G6PD deficiency, the red blood cells are more susceptible to oxidative damage due to a lack of protective enzymes.
Diagnosis[edit]
The diagnosis of conditions associated with degmacytes often involves a combination of clinical history, laboratory tests, and microscopic examination of a blood smear. The presence of bite cells can be a key indicator in diagnosing oxidative hemolytic anemia.
Treatment[edit]
Treatment of conditions associated with degmacytes depends on the underlying cause. In cases of G6PD deficiency, avoiding known oxidative stressors, such as certain medications and foods, is crucial. In more severe cases, medical intervention may be necessary to manage anemia and prevent complications.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian